Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Kitchen

Showing results (71-80 of 75) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 75 results.
British Journal of Obstetrics and Gynaecology|November 1, 1982
Infants born before 29 weeks gestation: survival and morbidity at 2 years of ageW H Kitchen, V Y Yu, A A Orgill, et al.
Journal of Paediatrics and Child Health|February 1, 1993
The cost of improving the outcome for infants of birthweight 500-999 g in Victoria. The Victorian Infant Collaborative Study GroupW H Kitchen, E Bowman, C Callanan, et al.
The British Journal of Dermatology|January 24, 2020
The Alopecia Areata Investigator Global Assessment scale: a measure for evaluating clinically meaningful success in clinical trialsK W Wyrwich, H Kitchen, S Knight, et al.
The British Journal of Dermatology|March 13, 2020
Development of the Scalp Hair Assessment PRO™ measure for alopecia areataK W Wyrwich, H Kitchen, S Knight, et al.
ESMO Open|April 10, 2026
Patient-reported outcomes and qualitative interviews in patients with estrogen receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer: results from the phase III EMBER-3 trialG Curigliano, J O'Shaughnessy, F-C Bidard, et al.
Pageof 8

Showing results (71-80 of 75) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 75 results.
British Journal of Obstetrics and Gynaecology|November 1, 1982
Infants born before 29 weeks gestation: survival and morbidity at 2 years of ageW H Kitchen, V Y Yu, A A Orgill, et al.
Journal of Paediatrics and Child Health|February 1, 1993
The cost of improving the outcome for infants of birthweight 500-999 g in Victoria. The Victorian Infant Collaborative Study GroupW H Kitchen, E Bowman, C Callanan, et al.
The British Journal of Dermatology|January 24, 2020
The Alopecia Areata Investigator Global Assessment scale: a measure for evaluating clinically meaningful success in clinical trialsK W Wyrwich, H Kitchen, S Knight, et al.
The British Journal of Dermatology|March 13, 2020
Development of the Scalp Hair Assessment PRO™ measure for alopecia areataK W Wyrwich, H Kitchen, S Knight, et al.
ESMO Open|April 10, 2026
Patient-reported outcomes and qualitative interviews in patients with estrogen receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer: results from the phase III EMBER-3 trialG Curigliano, J O'Shaughnessy, F-C Bidard, et al.
Pageof 8